Brambilla G, Martelli A, Sottofattori E
Institute of Pharmacology, University of Genoa, Italy.
Carcinogenesis. 1995 May;16(5):1239-42. doi: 10.1093/carcin/16.5.1239.
Nitrosation of propranolol, a beta-adrenergic blocking drug previously found to react with nitrite in HCl solution yielding a genotoxic nitrosamine, was examined under simulated gastric conditions. In the presence of a low concentration of nitrite (2.9 mM) and a therapeutic gastric concentration of the drug (5.4 mM), the yield of N-nitrosopropranolol was higher in simulated gastric juice, which contained both pepsin and thiocyanate, than in distilled water, and at pH 3.5 than at pH 1.0. A 55 microM concentration of N-nitrosopropranolol was reached after 180 min. It is reasonable to assume that the extremely small amounts of N-nitrosopropranolol formed in the human stomach should not represent a significant carcinogenic risk, but co-formulation of propranolol with ascorbic acid, which has been found to minimize the nitrosation reaction, might be useful to avoid a further, even if minimal, contribution to the already existing exposure to genotoxic chemicals.
在模拟胃部条件下,研究了普萘洛尔(一种β-肾上腺素能阻滞剂,此前发现其在盐酸溶液中与亚硝酸盐反应生成具有基因毒性的亚硝胺)的亚硝化作用。在低浓度亚硝酸盐(2.9 mM)和治疗性胃部药物浓度(5.4 mM)存在的情况下,含有胃蛋白酶和硫氰酸盐的模拟胃液中N-亚硝基普萘洛尔的产量高于蒸馏水中的产量,且在pH 3.5时高于pH 1.0时的产量。180分钟后,N-亚硝基普萘洛尔的浓度达到55 microM。有理由认为,在人类胃中形成的极少量N-亚硝基普萘洛尔不应构成重大致癌风险,但将普萘洛尔与已发现可使亚硝化反应降至最低的抗坏血酸共同配制,可能有助于避免对已存在的基因毒性化学物质暴露产生进一步的、即使是最小的影响。